PrecisionFDA and the National Cancer Institute’s (NCI) Clinical Proteomic Tumor Analysis Consortium (CPTAC) (in coordination with DREAM Challenges) are pleased to announce the
Learn More Mapping the complete target space of drugs and drug-like compounds, including both intended ‘primary targets’ as well as secondary ‘off-targets’,
Learn More In this Challenge on Single-Cell Transcriptomics, participants will reconstruct the location of single cells in the Drosophila embryo using single-cell
Learn More Polypharmacology has key advantages for a host of diseases including cancer, diabetes, and Mendelian diseases. Recent data supports the view
Learn More Transcription factors (TFs) are regulatory proteins that bind specific sequence motifs in the genome to activate or repress transcription of
Learn More Recent advances in mobile health have demonstrated great potential to leverage sensor-based technologies for quantitative, remote monitoring of health and
Learn More The highly distributed and disparate nature of genomic and clinical data generated around the world presents an enormous challenge for
Learn More Cancer is driven by aberrations in the genome [1,2], and these alterations manifest themselves largely in the changes in the
Learn More The Digital Mammography DREAM Challenge will attempt to improve the predictive accuracy of digital mammography for the early detection of
Learn More Multiple myeloma (MM) is a cancer of the plasma cells in the bone marrow, and its clinical course depends on
